Comparison of tamsulosin with tadalafil versus tamsulosin alone in patients with benign prostatic hyperplasia

Objective: The objective of the study is to compare the use of tamsulosin with tadalafil versus tamsulosin alone in the medical treatment of patients with benign prostatic hyperplasia (BPH) in Jos, using International prostate symptom score (IPSS), quality of life (QoL) scores, and maximum flow rate (Qmax). Material and Methods: A randomized longitudinal study among 56 consented patients with BPH at the Jos University Teaching Hospital. Patients had the IPSS questionnaire and QoL scores and Qmax assessed at baseline. Thereafter, patients were randomized into groups A (tamsulosin and tadalafil) or B (tamsulosin only) and reassessed after 12 weeks of therapy. Data were recorded in a structured proforma, and the Statistical Package for the Social Sciences version 23 was used for data collation. Results were presented in tables and a Student t -test was used for the analysis. A P < 0.05 was considered significant. Results: A total of 56 patients were studied with age ranging from 48 to 89 years, with a mean age of 61.82 ± 8.71 years. At baseline, the mean IPSS, QoL score, and Qmax for Group A were 14.28 ± 4.19, 4.29 ± 0.46, and 10.29 ± 3.05 and for Group B were 16.32 ± 2.83, 4.68 ± 0.72, and 7.43 ± 3.91. The assessment 12-week post-treatment showed that the mean IPSS, QoL score, and Qmax for patients in Group A were 9.73 ± 3.18, 3.19 ± 2.40, and 12.22 ± 2.97 and Group B were 11.18 ± 3.38, 2.89 ± 0.93, and 9.68 ± 2.95, respectively. Comparing the response to treatment in the two treatment groups using IPSS, QoL score, and Qmax, IPSS (1.618, P = 0.112) and QoL score (0.611, P = 0.544) were not statistically significant. However, the response in Qmax was statistically significant (3.191, P = 0.002). Conclusion: While combination therapy and tamsulosin monotherapy had a similar effect in improving IPSS and QoL scores, only the combination of tamsulosin with tadalafil had a significant effect in improving urine flow rate (Qmax).

Authors

Institutions

Publication Details

Journal
Adesh University Journal of Medical Sciences & Research
Published
2025-05-15
DOI
https://doi.org/10.25259/aujmsr_1_2025
Primary Topic
Urinary Bladder and Prostate Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comparison of tamsulosin with tadalafil versus tamsulosin alone in patients with benign prostatic hyperplasia

Ifiok Umana, Sunday Atinko, Oriazowan Julius Akhaine
1 links
Adesh University Journal of Medical Sciences & Research
Urinary Bladder and Prostate Research
article

Comparison of tamsulosin with tadalafil versus tamsulosin alone in patients with benign prostatic hyperplasia

Ifiok Umana, Sunday Atinko, Oriazowan Julius Akhaine
article en

Abstract

Objective: The objective of the study is to compare the use of tamsulosin with tadalafil versus tamsulosin alone in the medical treatment of patients with benign prostatic hyperplasia (BPH) in Jos, using International prostate symptom score (IPSS), quality of life (QoL) scores, and maximum flow rate (Qmax). Material and Methods: A randomized longitudinal study among 56 consented patients with BPH at the Jos University Teaching Hospital. Patients had the IPSS questionnaire and QoL scores and Qmax assessed at baseline. Thereafter, patients were randomized into groups A (tamsulosin and tadalafil) or B (tamsulosin only) and reassessed after 12 weeks of therapy. Data were recorded in a structured proforma, and the Statistical Package for the Social Sciences version 23 was used for data collation. Results were presented in tables and a Student t -test was used for the analysis. A P < 0.05 was considered significant. Results: A total of 56 patients were studied with age ranging from 48 to 89 years, with a mean age of 61.82 ± 8.71 years. At baseline, the mean IPSS, QoL score, and Qmax for Group A were 14.28 ± 4.19, 4.29 ± 0.46, and 10.29 ± 3.05 and for Group B were 16.32 ± 2.83, 4.68 ± 0.72, and 7.43 ± 3.91. The assessment 12-week post-treatment showed that the mean IPSS, QoL score, and Qmax for patients in Group A were 9.73 ± 3.18, 3.19 ± 2.40, and 12.22 ± 2.97 and Group B were 11.18 ± 3.38, 2.89 ± 0.93, and 9.68 ± 2.95, respectively. Comparing the response to treatment in the two treatment groups using IPSS, QoL score, and Qmax, IPSS (1.618, P = 0.112) and QoL score (0.611, P = 0.544) were not statistically significant. However, the response in Qmax was statistically significant (3.191, P = 0.002). Conclusion: While combination therapy and tamsulosin monotherapy had a similar effect in improving IPSS and QoL scores, only the combination of tamsulosin with tadalafil had a significant effect in improving urine flow rate (Qmax).

Adesh University Journal of Medical Sciences & ResearchVol. 7
National Hospital Abuja (NG), Jos University Teaching Hospital (NG), Federal Medical Centre (NG)
Openalex Percentile: Top 85%
Urinary Bladder and Prostate Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.